 |
|
|
|
 |
|
|
| Article 1 to 10 out of 10 concerning Charles River Laboratories, Inc.
|
-
Charles River Acquires NewLab BioQuality AG
(08 Aug 2008)
Charles River announced the acquisition of privately-held NewLab BioQuality AG (NewLab), a Dusseldorf, Germany-based contract service organization that provides safety and quality control services to biopharmaceutical clients. NewLab has ...
-
Charles River Laboratories Announces Plan to Construct New Preclinical Services Facility in Quebec
(29 Aug 2007)
Charles River Laboratories International, Inc. announced that it intends to build a new facility in Sherbrooke, Quebec, to support the company's expanding Preclinical Services business. Located in the newly constructed Sherbrooke Biomedical Park, ...
-
Charles River Establishes a New Facility in Korea to Provide Endosafe Products and Services
(12 Apr 2007)
Charles River Laboratories announced the establishment of Charles River Endosafe Korea. Effective May 1, 2007, Endosafe®products will be sold and supported directly by the new, wholly owned Korean operation. The focus of Endosafe Korea's scientific ...
-
Charles River Laboratories' Endosafe-Pts Completes Journey to the International Space Station
(16 Jan 2007)
Charles River Laboratories International, Inc. announced that its portable endotoxin testing system, the Endosafe(R) - PTS(TM), was recently launched into space aboard the space shuttle Discovery and successfully reached the International Space ...
-
Crucell Secures $16.2 million NIH Contract for HIV Vaccine Design and Development
(10 Oct 2006)
Crucell N.V. announced that it has secured a US$ 16.2 million contract from the National Institute of Allergy and Infectious Diseases, part of the U.S. National Institutes of Health (NIH), for the design and development of an HIV vaccine. The ...
-
Kendle Completes Acquisition of Phase II-IV Clinical Services Business of Charles River Laboratories International, Inc.
(22 Aug 2006)
Kendle has completed the acquisition of the Phase II-IV Clinical Services business of Charles River Laboratories International, Inc. With this move, Kendle strengthens its position as one of the leading global players in the clinical development ...
-
Strategic Alliance enabling the generation of genetically modified research models to assist the drug discovery process
(18 May 2006)
North American Collaboration between Charles River Laboratories and genOway
Charles River Laboratories, Inc. and genOway announced the establishment of a three-year North American collaboration. This strategic alliance will provide pharmaceutical, biotechnology, and academic researchers with innovative research models to ...
-
Charles River Laboratories Enters Worldwide Collaboration with Deltagen
(13 Dec 2005)
Charles River Laboratories announced a worldwide collaboration with Deltagen, Inc. Deltagen has created a repository of knockout mice. Under this new agreement, Charles River will act as Deltagen's exclusive provider of cryopreserved mouse embryos, ...
-
Genetic Monitoring Guidelines from Charles River Laboratories
(17 Jan 2005)
Before using inbred mouse lines in experiments, Charles River Laboratories recommends performing routine genetic monitoring to identify divergence from stock colonies as well as misbreeding events. Closed colonies inevitably diverge from each other, ...
-
Charles River Laboratories Buys Inveresk
(05 Jul 2004)
Create a Leading Global Partner to the Pharmaceutical and Biotechnology Industry
Charles River Laboratories Inc., the world's biggest provider of animals for drug research, on Thursday said it will acquire Inveresk Research Group Inc. in a $1.5 billion deal aimed at boosting its drug-testing business.Charles River, which raises ...
Additional information
Charles River Laboratories, Inc.
Wilmington, MA, USA
Company
|
|
|
|
|
|
Top
